Whole Foods Market® is recalling “Our Chefs’ Own” Spinach Orzo Salad sold in stores in Massachusetts, Connecticut, New Hampshire, Maine and Rhode Island due to an undeclared tree nut allergen. Only Spinach Orzo Salad with PLU 61159 and a “sold on” date of February 24 or before is included in this recall. The effected salad was sold from the chef cases or in prepackaged containers.
Read The Complete Story!
Category Archives: Food & Drug Recalls
Manzana Products Co., Inc. Issues Voluntary Recall of Apple Sauces Due to Potential Presence of Foreign Material
Manzana Products Co., Inc. is voluntarily recalling three different types of Trader Joe’s Unsweetened Apple Sauces due to the potential presence of glass pieces.
Read The Complete Story!
Manzana Products Co., Inc. Issues Voluntary Recall of Apple Sauces Due to Potential Presence of Foreign Material
Manzana Products Co., Inc. is voluntarily recalling three different types of Trader Joe’s Unsweetened Apple Sauces due to the potential presence of glass pieces.
Read The Complete Story!
Lakeview Cheese and Bashas’ Family of Stores Issue Voluntary Cheese Recall
Out of an abundance of caution and with an emphasis on customers’ wellness and safety, Lakeview Cheese and Bashas’ Family of Stores are proactively recalling various types of Colby cheese due to a potential contamination of Listeria monocytogenes. It’s important to note that no illnesses have been reported to date.
Avella Specialty Pharmacy Issues Voluntary Nationwide Recall of all Sterile Products Produced at Advanced Pharma Houston Location from September 1, 2016 through February 16, 2017 Due to Potential Inaccuracy of Latex Free Label Reference
Advanced Pharma, Inc. d/b/a Avella of Houston is conducting a voluntary recall of all unexpired sterile injectable products labeled “latex free” that were produced at Advanced Pharma, Inc.’s Houston location between September 1, 2016 and February 16, 2017 to the user level (hospitals and institutions) because such products may contain synthetic latex and/or natural latex. Avella and Advanced Pharma have been unable to confirm with clarity whether its “latex free” label statements are accurate in all cases and are therefore conducting this recall in an abundance of caution.
FDA clears test to help manage antibiotic treatment for lower respiratory tract infections and sepsis
The U.S. Food and Drug Administration today cleared the expanded use of the Vidas Brahms PCT Assay to help health care providers determine if antibiotic treatment should be started or stopped in patients with lower respiratory tract infections, such as community-acquired pneumonia, and stopped in patients with sepsis. This is the first test to use procalcitonin (PCT), a protein associated with the body’s response to a bacterial infection, as a biomarker to help make antibiotic management decisions in patients with these conditions.
FDA clears test to help manage antibiotic treatment for lower respiratory tract infections and sepsis
The U.S. Food and Drug Administration today cleared the expanded use of the Vidas Brahms PCT Assay to help health care providers determine if antibiotic treatment should be started or stopped in patients with lower respiratory tract infections, such as community-acquired pneumonia, and stopped in patients with sepsis. This is the first test to use procalcitonin (PCT), a protein associated with the body’s response to a bacterial infection, as a biomarker to help make antibiotic management decisions in patients with these conditions.
FDA clears test to help manage antibiotic treatment for lower respiratory tract infections and sepsis
The U.S. Food and Drug Administration today cleared the expanded use of the Vidas Brahms PCT Assay to help health care providers determine if antibiotic treatment should be started or stopped in patients with lower respiratory tract infections, such as community-acquired pneumonia, and stopped in patients with sepsis. This is the first test to use procalcitonin (PCT), a protein associated with the body’s response to a bacterial infection, as a biomarker to help make antibiotic management decisions in patients with these conditions.
FDA allows marketing of test to identify organisms that cause bloodstream infections and provide antibiotic sensitivity results
The U.S. Food and Drug Administration today allowed marketing of the PhenoTest BC Kit, performed on the Pheno System. This is the first test to identify organisms that cause bloodstream infections and provide information about which antibiotics the organism is likely to respond to (antibiotic sensitivity).
FDA allows marketing of test to identify organisms that cause bloodstream infections and provide antibiotic sensitivity results
The U.S. Food and Drug Administration today allowed marketing of the PhenoTest BC Kit, performed on the Pheno System. This is the first test to identify organisms that cause bloodstream infections and provide information about which antibiotics the organism is likely to respond to (antibiotic sensitivity).